Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A24949 | 22326764 | Clin Res Hepatol Gastroenterol | HCC and NASH: how strong is the clinical demonstration? | 2012 | Details |
| A24950 | 22326465 | J Hepatol | Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. | 2012 | Details |
| A24951 | 22326434 | Gastroenterology | Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. | 2012 | Details |
| A24952 | 22319959 | Acta Gastroenterol Belg | Risk factors for non-alcoholic fatty liver disease in a Chinese population. | 2011 | Details |
| A24954 | 22315014 | Endocrine | The role of pro/anti-inflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy. | 2012 | Details |
| A24958 | 22312449 | World J Hepatol | Overview of screening methods for fatty liver disease in children. | 2012 | Details |
| A24961 | 22308841 | J Pediatr Endocrinol Metab | The prevalence of non-alcoholic fatty liver disease and metabolic syndrome in obese children. | 2011 | Details |
| A24964 | 22307032 | Gastroenterology | Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice. | 2012 | Details |
| A24966 | 22300605 | Endocrinol Nutr | The role of gut hormones in controlling the food intake: what is their role in emerging diseases? | 2012 | Details |
| A24968 | 22297845 | Nature | Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. | 2012 | Details |
| A24969 | 22297300 | Am J Physiol Endocrinol Metab | Adiponectin promoter activator NP-1 reduces body weight and hepatic steatosis in high-fat diet-fed animals. | 2012 | Details |
| A24972 | 22294100 | Cell Mol Life Sci | A role for sphingolipids in the pathophysiology of obesity-induced inflammation. | 2012 | Details |
| A24973 | 22291824 | Arch Med Sci | Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study. | 2011 | Details |
| A24976 | 22288305 | Eur Rev Med Pharmacol Sci | The psoriatic patient profile for infliximab. | 2011 | Details |
| A24978 | 25586046 | Clin Obes | Liver fat content investigated by magnetic resonance spectroscopy in obese children and youths included in multidisciplinary treatment. | 2012 | Details |
| A24981 | 22282244 | J Huazhong Univ Sci Technolog Med Sci | Relationship between serum TSH level with obesity and NAFLD in euthyroid subjects. | 2012 | Details |
| A24995 | 22268100 | Am J Physiol Gastrointest Liver Physiol | Consumption of a high-fat diet rapidly exacerbates the development of fatty liver disease that occurs with chronically elevated glucocorticoids. | 2012 | Details |
| A25001 | 22257474 | J Dig Dis | Liver X receptors bridge hepatic lipid metabolism and inflammation. | 2012 | Details |
| A25004 | 22253482 | Gut | Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice. | 2012 | Details |
| A25007 | 22249728 | Nat Rev Gastroenterol Hepatol | Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach. | 2012 | Details |
| A25008 | 22249092 | Saudi J Gastroenterol | The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children. | 2012 | Details |
| A25011 | 22237875 | JPEN J Parenter Enteral Nutr | Nonalcoholic fatty liver disease in pediatric patients. | 2012 | Details |
| A25015 | 22246329 | Eur J Gastroenterol Hepatol | The association between adipocytokines and biomarkers for nonalcoholic fatty liver disease-induced liver injury: a study in the general population. | 2012 | Details |
| A25023 | 22239625 | Curr Vasc Pharmacol | Non-alcoholic fatty liver disease in type 2 diabetes: pathogenesis and treatment options. | 2012 | Details |
| A25024 | 22239319 | Obes Rev | Oestradiol is a protective factor for non-alcoholic fatty liver disease in healthy men. | 2012 | Details |
| A25030 | 22229957 | Int J Food Sci Nutr | Serum vitamin B12 and folate levels in patients with non-alcoholic fatty liver disease. | 2012 | Details |
| A25031 | 22228717 | Diabetes | TIMP3 overexpression in macrophages protects from insulin resistance, adipose inflammation, and nonalcoholic fatty liver disease in mice. | 2012 | Details |
| A25034 | 22227333 | Eur J Pharmacol | Flavangenol (pine bark extract) and its major component procyanidin B1 enhance fatty acid oxidation in fat-loaded models. | 2011 | Details |
| A25038 | 22224077 | Hepat Mon | Obesity and air pollution: global risk factors for pediatric non-alcoholic fatty liver disease. | 2011 | Details |
| A25040 | 22221818 | Liver Int | The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance. | 2011 | Details |
| A25044 | 22221215 | Nutr Rev | Therapeutic potential of green tea in nonalcoholic fatty liver disease. | 2012 | Details |
| A25045 | 22219597 | World J Gastroenterol | Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease. | 2011 | Details |
| A25050 | 22213436 | Hepatology | Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. | 2012 | Details |
| A25055 | 22209679 | Clin Nutr | Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetes. | 2011 | Details |
| A25056 | 33907358 | J Proteomics Bioinform | High Fat Diet-Induced Changes in Hepatic Protein Abundance in Mice. | 2012 | Details |
| A25061 | 24713801 | Ann Gastroenterol | Non-alcoholic fatty liver disease may develop in individuals with normal body mass index. | 2012 | Details |
| A25062 | 24436572 | Curr Trends Endocinol | Fatty acid metabolism and thyroid hormones. | 2012 | Details |
| A25063 | 24331173 | Obes Res Clin Pract | Hepatic tumor necrosis factor-α, leptin and adiponectin expression in morbid obese patients: Clinicopathological correlations. | 2013 | Details |
| A25064 | 24024115 | Mol Metab | Obesity and the gut microbiome: Striving for causality. | 2012 | Details |
| A25065 | 23930060 | Hippokratia | Fatty liver disease in an autopsy series of children and adolescents. | 2012 | Details |
| A25067 | 22201932 | Front Biosci (Elite Ed) | Influence of lifestyle habits, nutritional status and insulin resistance in NAFLD. | 2012 | Details |
| A25071 | 22196506 | J Acupunct Meridian Stud | Ayurvedic formulation of Liv-Pro-08 reduces nonalcoholic fatty liver disease in rats fed with high-fat diet. | 2011 | Details |
| A25078 | 22187656 | J Lipids | Non-alcoholic Fatty liver disease: the bile Acid-activated farnesoid x receptor as an emerging treatment target. | 2011 | Details |
| A25086 | 22183689 | Hepatology | Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A25087 | 22183113 | Curr Opin Infect Dis | From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management. | 2012 | Details |
| A25088 | 22182810 | Dis Markers | SREBP-2 1784 G/C genotype is associated with non-alcoholic fatty liver disease in north Indians. | 2011 | Details |
| A25089 | 22182015 | Scand J Gastroenterol | Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors. | 2011 | Details |
| A25097 | 22173246 | Singapore Med J | Metabolic syndrome. | 2011 | Details |
| A25098 | 22173168 | J Hepatol | The interaction of hepatic lipid and glucose metabolism in liver diseases. | 2011 | Details |
| A25099 | 22173167 | J Hepatol | Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®. | 2011 | Details |
| A25100 | 22173165 | J Hepatol | Accumulation of endoplasmic reticulum stress and lipogenesis in the liver through generational effects of high fat diets. | 2011 | Details |
| A25112 | 22161114 | Obes Surg | Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients. | 2012 | Details |
| A25115 | 22157544 | J Nutr | Green tea extract suppresses NFκB activation and inflammatory responses in diet-induced obese rats with nonalcoholic steatohepatitis. | 2011 | Details |
| A25140 | 22147010 | Endocrinology | Thyroid hormone receptor-α gene knockout mice are protected from diet-induced hepatic insulin resistance. | 2011 | Details |
| A25141 | 22143620 | Int J Obes (Lond) | Hepatic left lobe volume is a sensitive index of metabolic improvement in obese women after gastric banding. | 2011 | Details |
| A25144 | 22140659 | Acta Biochim Pol | Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease. | 2011 | Details |
| A25148 | 22136330 | Liver Int | Overexpression of 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease. | 2011 | Details |
| A25154 | 22129796 | Gastroenterol Nurs | Predictors of nonalcoholic steatohepatitis in obese children. | 2012 | Details |
| A25155 | 22129639 | J Nutr Biochem | The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease. | 2011 | Details |
| A25161 | 22122481 | Curr Pharm Biotechnol | Non-alcoholic steatohepatitis: new insights from OMICS studies. | 2012 | Details |
| A25165 | 22120206 | J Hepatol | Obesity, inflammation, and liver cancer. | 2011 | Details |
| A25166 | 22119618 | Dig Liver Dis | N-glycan based biomarker distinguishing non-alcoholic steatohepatitis from steatosis independently of fibrosis. | 2011 | Details |
| A25169 | 22118645 | Int J Exp Pathol | Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet. | 2011 | Details |
| A25175 | 22111971 | Aliment Pharmacol Ther | Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children. | 2011 | Details |
| A25180 | 22110273 | World J Gastroenterol | Non-alcoholic fatty liver disease and metabolic syndrome in obese children. | 2011 | Details |
| A25181 | 22110265 | World J Gastroenterol | Physical activity and nutrition attitudes in obese Hispanic children with non-alcoholic steatohepatitis. | 2011 | Details |
| A25182 | 22110053 | Gut | Genetic determinants of alcoholic liver disease. | 2011 | Details |
| A25183 | 22108808 | Obes Surg | Effect of bariatric surgery on liver fibrosis. | 2012 | Details |
| A25187 | 22106162 | Orv Hetil | [Role of autophagy in the pathogenesis of liver diseases]. | 2011 | Details |
| A25191 | 22103753 | Pharm Biol | Fish oil improves lipid metabolism and ameliorates inflammation in patients with metabolic syndrome: impact of nonalcoholic fatty liver disease. | 2011 | Details |
| A25192 | 22103042 | Acta Gastroenterol Belg | Lean non-alcoholic fatty liver disease (Lean-NAFLD): a major cause of cryptogenic liver disease. | 2011 | Details |
| A25197 | 22098614 | Liver Int | Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients. | 2011 | Details |
| A25198 | 22098270 | Liver Int | Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25202 | 22097199 | Zhongguo Zhong Xi Yi Jie He Za Zhi | [Study on the distribution and characteristics of Chinese medicine syndrome in patients with nonalcoholic fatty liver disease]. | 2011 | Details |
| A25204 | 22095799 | Hepatology | Hepatic ratio of phosphatidylcholine to phosphatidylethanolamine predicts survival after partial hepatectomy in mice. | 2012 | Details |
| A25206 | 22094893 | Curr Top Microbiol Immunol | Contribution of the intestinal microbiota to human health: from birth to 100 years of age. | 2013 | Details |
| A25207 | 22093857 | Pediatr Clin North Am | Advances in pediatric nonalcoholic fatty liver disease. | 2011 | Details |
| A25208 | 22093607 | Gastroenterol Hepatol | Genetic factors associated with the presence and progression of nonalcoholic fatty liver disease: a narrative review. | 2011 | Details |
| A25217 | 22087137 | Hepat Mon | HCC, diet and metabolic factors: Diet and HCC. | 2011 | Details |
| A25221 | 22082482 | Curr Mol Med | The emerging role of endocrine disruptors in pathogenesis of insulin resistance: a concept implicating nonalcoholic fatty liver disease. | 2012 | Details |
| A25226 | 22081615 | J Am Coll Nutr | Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease. | 2011 | Details |
| A25227 | 22077984 | Clin Endocrinol (Oxf) | Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels. | 2012 | Details |
| A25236 | 22064361 | Free Radic Biol Med | Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. | 2011 | Details |
| A25237 | 22064320 | Lab Invest | A novel murine model for non-alcoholic steatohepatitis developed by combination of a high-fat diet and oxidized low-density lipoprotein. | 2011 | Details |
| A25238 | 22059955 | Health Technol Assess | Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review. | 2011 | Details |
| A25239 | 22059453 | Aliment Pharmacol Ther | Caffeine is protective in patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25241 | 22056763 | Biochim Biophys Acta | Roles of PPARs in NAFLD: potential therapeutic targets. | 2011 | Details |
| A25251 | 22045426 | Dis Markers | Serum progranulin as an independent marker of liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease. | 2011 | Details |
| A25252 | 22043839 | Expert Opin Pharmacother | Managing the combination of nonalcoholic fatty liver disease and metabolic syndrome. | 2011 | Details |
| A25253 | 22043827 | Expert Opin Pharmacother | Statins as potential treatment for cholesterol gallstones: an attempt to understand the underlying mechanism of actions. | 2011 | Details |
| A25255 | 22030814 | Acta Cir Bras | Fructose and NAFLD: metabolic implications and models of induction in rats. | 2011 | Details |
| A25261 | 22027586 | J Hepatol | Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans. | 2011 | Details |
| A25262 | 22027584 | J Hepatol | Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe. | 2011 | Details |
| A25265 | 22024606 | Med Princ Pract | Nonalcoholic fatty liver disease of two ethnic groups in Kuwait: comparison of prevalence and risk factors. | 2011 | Details |
| A25266 | 22024495 | Nutr Res | Adverse metabolic effects of a hypercaloric, high-fat diet in rodents precede observable changes in body weight. | 2011 | Details |
| A25270 | 22023985 | J Hepatol | Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. | 2011 | Details |
| A25283 | 22008843 | Food Funct | The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity. | 2011 | Details |
| A25284 | 22002020 | Curr Opin Lipidol | Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic. | 2011 | Details |
| A25286 | 21999238 | J Agric Food Chem | Inhibitory effect of blueberry polyphenolic compounds on oleic acid-induced hepatic steatosis in vitro. | 2011 | Details |
| A25287 | 21994008 | Hepatology | Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. | 2012 | Details |